GSK2879552 dihydrochloride - LSD1 Inhibitor. CAS# 1902123-72-1 60306 12(8):1442-52

12(8):1442-52

BG45 was used at 10 µM final concentration in various in vitro assays

is a potent inhibitor of class I PI3K kinases with an IC50 of 19 nM

which can be used to investigate PHD inhibition and demonstrate that PHD inhibitors offer great promise for the treatment of inflammation-induced anemia

It modulates the coupling of Smo with its downstream effector by interacting with the Smo heptahelical domain (KD = 59 nM)

GSK2879552 dihydrochloride - LSD1 Inhibitor. CAS# 1902123-72-1 60306 12(8):1442-52GSK2879552 dihydrochloride, CAS No. 1902123 72 1, is a highly potent, selective and orally bioavailable irreversible inhibitor of Lysine Specific Demethylase 1 (LSD1). It is highly selective over related enzymes such as MAO A B. A proliferation screen of cell lines representing a number of tumor types indicated that small cell lung carcinoma (SCLC) is sensitive to GSK2879552s inhibition. It increases H3K4 methylation selectively at genomic regions